A role for Dicer in immune regulation. by Cobb, Bradley S et al.
UCLA
UCLA Previously Published Works
Title
A role for Dicer in immune regulation.
Permalink
https://escholarship.org/uc/item/6j70v2xd
Journal
The Journal of experimental medicine, 203(11)
ISSN
0022-1007
Authors
Cobb, Bradley S
Hertweck, Arnulf
Smith, James
et al.
Publication Date
2006-10-23
DOI
10.1084/jem.20061692
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
ARTICLE
JEM © The Rockefeller University Press $8.00
Vol. 203, No. 11, October 30, 2006 2519–2527 www.jem.org/cgi/doi/10.1084/jem.20061692
2519
Specialized cell types in multicellular organisms 
are defi ned by specifi c patterns of gene expres-
sion (1). In addition to the transcriptional regula-
tion of protein-coding genes, posttranscriptional 
regulation is emerging as an important mech-
anism for the control of gene expression. In 
particular, the noncoding transcripts of several 
hundred micro RNA (miRNA) genes aff ect 
the translation and/or the stability of protein-
coding transcripts (2). Long primary miRNAs 
are processed into hairpins of 60–70 nucleotides 
in length by a complex containing the nuclear 
RNase III enzyme Drosha and DGCR8 (Di-
George syndrome critical region 8 homologue; 
references 3 and 4). These pre-miRNAs are ex-
ported to the cytoplasm and further processed 
into mature, double-stranded miRNAs of 22 
nucleotides in length by a complex containing 
the RNase III enzyme Dicer and TRBP (human 
immunodefi ciency virus 1–transactivating re-
sponse RNA-binding protein; reference 5). 
After their unwinding, one of the miRNA strands 
remains associated with the RNA-induced 
silencing complex, which controls mRNA 
translation and/or the degradation based on 
sequence complementarity between RNA-
induced silencing–associated miRNAs and the 
3′ untranslated region (UTR) of target mRNAs 
(2). There are several hundred known miRNAs, 
each of which potentially targets multiple 
transcripts. Therefore, it is likely that a substan-
tial proportion of protein-coding transcripts is 
subject to miRNA regulation (6–8). miRNAs 
are expressed in a cell type– and developmental 
stage–specifi c fashion with distinct patterns in 
embryonic stem cells/early embryos and com-
mitted lineages (2). The miRNA-generating 
enzyme Dicer is required for embryonic devel-
opment (9, 10), and Dicer-defi cient embryonic 
stem cells fail to diff erentiate in vitro or to con-
tribute to embryonic development in vivo (11).
A role for miRNAs in hematopoiesis had 
been predicted based on recurrent breakpoints 
in leukemias at chromosomal locations that en-
code miRNAs (12) and a causal link between 
miRNA expression and leukemia has recently 
been demonstrated (13). Surveys of miRNA 
expression in hematopoiesis have shown lin-
eage and developmental stage-specifi c patterns 
(14, 15), and the overexpression of one miRNA, 
miR-181, in hematopoietic precursor cells can 
bias lymphoid diff erentiation toward the B cell 
lineage at the expense of T cells (14). Condi-
tional Dicer alleles avoid the lethality resulting 
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Micro RNAs (miRNAs) regulate gene expression at the posttranscriptional level. Here we 
show that regulatory T (T reg) cells have a miRNA profi le distinct from conventional CD4 T 
cells. A partial T reg cell–like miRNA profi le is conferred by the enforced expression of 
Foxp3 and, surprisingly, by the activation of conventional CD4 T cells. Depleting miRNAs by 
eliminating Dicer, the RNAse III enzyme that generates functional miRNAs, reduces T reg 
cell numbers and results in immune pathology. Dicer facilitates, in a cell-autonomous 
fashion, the development of T reg cells in the thymus and the effi cient induction of Foxp3 
by transforming growth factor 𝛃. These results suggest that T reg cell development involves 
Dicer-generated RNAs.
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from constitutive Dicer defi ciency (9) and give insight into 
the role of Dicer-dependent RNAs in specifi c lineages. Dicer 
deletion early in T cell development induced by a Cre trans-
gene driven by the lck promoter (lckCre, expressed from the 
double-negative [DN] 2 stage onward; reference 16) resulted 
in a sharp reduction of miRNAs by the double-positive (DP) 
stage and a 10-fold drop in the number of TCR-αβ thymo-
cytes (17). The CD4/CD8 lineage choice appeared largely 
intact, including the up-regulation of lineage-specifi c genes 
and the stable silencing of Tdt, which is expressed in DP but 
not in single-positive (SP) thymocytes (17, 18). Deletion of 
Dicer later in T cell development (induced by a Cre transgene 
driven by the CD4 promoter, CD4Cre) resulted in moder-
ately reduced T cell numbers (19 and unpublished data) and a 
failure to silence IFN-γ expression under Th2 polarizing con-
ditions (19). Considering the importance of miRNA-mediated 
posttranscriptional regulation (8) and the requirement for 
Dicer in embryonic development (9), it was surprising that 
T cell development and diff erentiation progressed relatively 
normally in the absence of Dicer (17, 19).
Regulatory CD4 T (T reg) cells are essential for immune 
regulation (20, 21). They are characterized by the constitu-
tive expression of CD25, the α chain of the high affi  nity IL-2 
receptor, glucocorticoid-induced tumor necrosis factor re-
ceptor (GITR), CTLA4, and the forkhead transcription fac-
tor Foxp3, which is both necessary and suffi  cient for T reg 
cell function (22–28). T reg cells arise “naturally” during 
T cell diff erentiation in the thymus (20, 21) and their 
 frequencies can be manipulated experimentally (27, 28). 
Nevertheless, the rules that govern T reg cell diff erentiation 
are incompletely understood, which, combined with their 
potential to balance autoimmunity and immune pathology 
on the one hand and eff ective immunity to infections and tu-
mors on the other, explains why T reg cells currently attract 
special attention (20, 21). To gain insight into the biology of 
T reg cells we have analyzed their miRNA expression. We 
fi nd that natural T reg cells and conventional CD4 T cells 
have distinctly diff erent miRNA profi les. Interestingly, the 
miRNA expression profi le of natural T reg cells shows strong 
similarities to that of activated conventional CD4 T cells. 
Collectively, with the constitutive expression of several pro-
tein-coding genes usually expressed in response to activation 
(CD25, CTLA4, and GITR), these data suggest that T reg 
cells represent a state of partial activation. Analysis of mice 
that are depleted of miRNAs in the T cell lineage as a result 
of the loss of Dicer function uncovers a role for Dicer in the 
generation of natural T reg cells in vivo, and the in vitro in-
duction of Foxp3 by TGF-β. Mice lacking Dicer in the T 
cell lineage are prone to immune pathologies, indicating a 
role for Dicer in the regulation of the immune system.
RESULTS
Natural T reg cells and conventional CD4+ T cells 
have distinct miRNA profi les
We isolated natural T reg cells and conventional CD4 
LN T cells by staining and sorting CD4+25+GITR+ and 
CD4+25−GITR− subsets (Fig. 1 a). An aliquot was stained 
for Foxp3, confi rming expression in the CD4+25+GITR+ 
(87% Foxp3+) but not the CD4+25−GITR− subset (1% 
Foxp3+; Fig. 1 a). Low molecular weight RNA was ex-
tracted from conventional T cells and T reg cells from three 
independent sorts. Each set of samples was hybridized to mi-
croarrays containing oligonucleotide probes complementary 
to 173 known miRNAs (29). Two hybridizations (chip 1 
and chip 2 in Fig. 1 b) were performed for each biologi-
cal replicate (Fig. 1 b, A–C) using reciprocal labeling with 
Cy3/Cy5 and Cy5/Cy3 to off set possible detection bias. 
This dataset was subjected to signifi cance analysis of micro-
arrays (SAM), in which each miRNA is assigned a score on 
the basis of its change in expression relative to the standard 
deviation of repeated measurements (30). SAM identifi ed 68 
miRNAs that were diff erentially expressed between natural 
T reg cells and conventional CD4+CD25− T cells (Fig. 1 c). 
35 miRNAs were preferentially expressed in T reg cells 
 (including miR-223, miR-146, miR-21, miR-22, miR-23a 
and b, miR-24, miR-214, miR-155, and others) and 33 
were down-regulated in T reg cells (including miR-142-5p 
and -3p, miR-30b, c, e, and members of the Let-7 family). 
Diff erential miRNA expression was validated by real-time 
PCR and Northern blotting (Fig. 1, d and e).
Conventional CD4 T cells transiently adopt a T reg cell–like 
miRNA expression profi le in response to activation
From the dataset described in Fig. 1, we selected the 40 
miRNAs to which SAM analysis had assigned the lowest q 
values, indicative of false discovery rates of 0–0.5%. 20 of 
these miRNAs were overexpressed in T reg cells and 20 
were down-regulated in T reg cells compared with conven-
tional CD4 T cells. We then used miRNA microarrays to 
track the expression of these miRNAs during the activation 
of conventional CD4 T cells (Fig. 2 a). Strikingly, the 
miRNA profi le of conventional CD4 T cells began to re-
semble that of T reg cells so that 3 d after activation, 9 of the 
20 most T reg cell–specifi c miRNAs were up-regulated (Fig. 
2 b, yellow) and 11 of the 20 miRNAs most underexpressed 
in T reg cells were down-regulated (Fig. 2 b, blue). This pat-
tern was highly nonrandom because none of 20 miRNAs 
overexpressed in T reg cells became down-regulated, and 
none of 20 miRNAs underexpressed in T reg cells became 
up-regulated in activated conventional T cells (Fig. 2 b). 
miRNA expression by activated T cells was dynamic so that 
miRNAs that had been selected for diff erential expression 
between T reg cells and naive CD4 T cells began to show a 
positive correlation between T reg cells and activated T cells 
24 h after activation (R2 = 0.28). By day 3 of activation, this 
positive correlation strengthened to R2 = 0.6 and then de-
clined again (day 10, R2 = 0.03; Fig. 2 c). Hence, conven-
tional CD4 T cells transiently adopt a T reg cell–like miRNA 
profi le during activation.
To determine whether Foxp3, the signature transcription 
factor of T reg cells, plays a role in defi ning the T reg cell 
miRNA expression profi le, we activated conventional CD4 
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T cells and transduced them with retroviruses encoding 
Foxp3-IRES-GFP or IRES-GFP alone. GFP+ cells were 
sorted 3–4 d later and, as expected, intracellular staining 
showed the presence of Foxp3 protein in Foxp3-IRES-
GFP–transduced cells but not in cells transduced with the 
control vector (Fig. 3 a). We then compared miRNA expres-
sion between Foxp3 and control vector–transduced cells after 
72 (Fig. 3 b) and 96 h (not depicted) and found that 9 of the 
10 miRNAs that were up-regulated in Foxp3-expressing 
cells at both time points were among the top 20 miRNAs 
preferentially expressed in T reg cells (Fig. 3 c, yellow). 
Among the miRNAs overexpressed in Foxp3-transduced 
cells was miR-146, which is overexpressed by T reg cells 
but not by activated T cells (see above). Conversely, 6 of the 
Figure 1. The miRNA profi le of natural T reg cells is distinct from 
that of conventional CD4+CD25− T cells. (a) Natural T reg cells and 
conventional CD4 LN T cells were isolated as CD4+25+GITR+ and 
CD4+25−GITR− populations. Intracellular staining confi rmed the expres-
sion of Foxp3 in the CD4+25+GITR but not the CD4+25−GITR− subset. 
(b) Low molecular weight RNA from conventional T cells and T reg cells was 
labeled with Cy3 and Cy5 and hybridized to microarrays containing oligo-
nucleotide probes corresponding to the known miRNA sequences. The 
heat map summarizes three biological replicates (A–C) and six technical 
replicates, including dye swaps for each set. Red indicates overexpression 
in T reg cells, green indicates underexpression in T reg cells, and gray indi-
cates no signal. (c) Scatter plot of differential miRNA expression between 
T reg cells and conventional CD4 T cells according to the SAM algorithm. 
Data points outside the diagonal blue lines are differentially expressed. 
miRNAs up-regulated in T reg cells are shown in red, and miRNAs down-
regulated in T reg cells are shown in green. (d) Differential miRNA expres-
sion by real-time PCR analysis of mature miRNAs. 24 miRNAs were 
analyzed and the real-time PCR results confi rmed the array data in all but 
Figure 2. The T reg cell miRNA expression profi le bears an activa-
tion signature. (a) miRNA array comparison of 72-h activated T cells 
versus naive T cells. Conventional CD4+25− T cells were sorted and acti-
vated using plate-bound anti-TCR and anti-CD28. Low molecular weight 
RNA was extracted from freshly isolated CD4+25− T cells and after 1, 3, 
and 10 d of activation and hybridized to miRNA arrays as in Fig. 1. (b) T 
cell activation results in the up-regulation of several miRNAs that are 
overexpressed in T reg cells (highlighted in yellow) and in the down-
regulation of several miRNAs that are underexpressed in T reg cells (high-
lighted in blue). A kinetic analysis of day 1, 3, and 10 time points is 
presented in Fig. S1. (c) miRNA expression ratios between T reg cells/naive 
CD4 T cells are plotted against activated CD4/naive CD4 for days 1, 3, and 
10 after activation. A positive correlation develops by day 1 after activa-
tion, increases in signifi cance by day 3, and declines by day 10. Microarray 
data is available under accession number GSE6006.
two cases (miR-15a and 191), which we omitted from our subsequent 
analysis. (e) Differential miRNA expression confi rmed by Northern blotting. 
Microarray data is available under accession number GSE6003.
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10 miRNAs down-regulated in Foxp3-transduced cells were 
among the 20 most underexpressed miRNAs in T reg cells 
(Fig. 3 c, blue). This analysis shows that Foxp3 directly or in-
directly contributes to the profi le of miRNA expression in 
T reg cells.
Absence of the miRNA-generating RNase III enzyme Dicer 
from the T cell lineage results in reduced numbers 
of natural T reg cells and immune pathology
The RNase III enzyme Dicer is essential for the processing of 
pre-miRNAs into mature, functional miRNAs; therefore, its 
deletion provides a genetic test for the relevance of miRs to 
T reg cell biology. In the conditional lckCre Dicer deletion 
model we had analyzed previously (17), thymocyte numbers 
are reduced 10-fold and there are very few peripheral T cells 
(not depicted), precluding an analysis of the involvement of 
Dicer-generated RNAs in T reg cell development. We 
therefore crossed our conditional Dicer allele with CD4Cre, 
which deletes during the DN/DP transition (16, 19) signifi -
cantly later during T cell development than lckCre (16, 17). 
Dicer deletion was 90% in DP thymocytes, mature miRNAs 
were still abundant at the DP stage, and thymocyte numbers 
were normal in CD4Cre dicer∆/∆ mice (19 and not depicted). 
Dicer deletion was essentially complete in CD4Cre dicer∆/∆ 
Figure 3. Foxp3 confers aspects of the T reg cell miRNA profi le. 
(a) CD4+CD25− cells activated overnight with plate-bound anti-TCR and 
anti-CD28 were transduced with Foxp3-IRES-GFP or IRES-GFP control 
vector. GFP-expressing cells were sorted 72 or 96 h later, and intracellular 
staining of GFP+ cells confi rmed Foxp3 expression in Foxp3-IRES-GFP–
transduced but not in control cells. (b) miRNA microarray analysis of 
Foxp3-IRES-GFP– versus IRES-GFP–transduced cells 72 h after Foxp3 
transduction. The experiment was repeated at 96 h after Foxp3 transduc-
tion (not depicted). (c) Foxp3-transduced CD4 T cells overexpress and 
underexpress a subset of miRNAs that are overexpressed (yellow) or un-
derexpressed (blue) in natural T reg cells (from Fig. 1). Microarray data is 
available under accession number GSE6007.
Figure 4. Reduced numbers of natural T reg cells and immune pa-
thology in the absence of the miRNA-generating RNase III enzyme 
Dicer. (a) Splenocytes from CD4Cre dicer∆/∆ mice and dicerlox/lox controls 
were stained for CD4, CD25, and Foxp3 gated on CD4-expressing cells. 
(b) Quantitative RT-PCR of Foxp3 RNA levels in dicerlox/lox and CD4Cre dicer∆/∆ 
CD4+ and CD8+ splenocytes and CD4 SP thymocytes. (c) Top: Normal co-
lonic mucosa of a dicerlox/lox control mouse (Bar, 400 μm). Middle: Colon 
histology of a CD4Cre dicer∆/∆ mouse with active colitis. The lamina pro-
pria shows a dense infi ltrate of infl ammatory cells with a sparse infi ltrate 
extending into the submucosa (Bar, 400 μm). Bottom: High power view of 
CD4Cre dicer∆/∆ colonic mucosa with crypt abscess formation (arrow), 
focal gland destruction, and abscess formation (arrowheads; Bar, 100 μm).
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SP thymocytes and mature miRNAs were reduced 10-fold 
in naive CD4 peripheral T cells (19 and not depicted). Adult 
CD4Cre dicer∆/∆ mice have moderately reduced numbers 
of peripheral CD4 T cells (19 and not depicted). Among 
these CD4 T cells, we found a substantial reduction in the 
frequency of natural T reg cells (2.7 ± 0.3% in CD4Cre 
dicer∆/∆ CD4 spleen cells, 7.5 ± 2.5% in dicerlox/lox CD4 spleen, 
n = 15, ratio = 2.8; 3.3 ± 0.8% in CD4Cre dicer∆/∆ CD4 LN 
cells, 7.6 ± 0.8% in dicerlox/lox CD4 LN, n = 13, ratio = 2.3; 
0.8 ± 0.2% in CD4Cre dicer∆/∆ CD4 SP thymocytes, 3.7 ± 
0.5% in dicerlox/lox CD4 SP thymocytes, n = 4, ratio = 4.6) 
and in the expression of Foxp3 mRNA compared with 
 dicerlox/lox controls (Fig. 4, a and b). The introduction of a 
Bcl-2 transgene failed to correct this defi ciency in natural 
T reg cells (not depicted).
Splenomegaly and enlarged intestinal LNs as well as mac-
roscopic thickening of the colon were noted in the majority 
of our CD4Cre dicer∆/∆ mice aged between 3 and 4 mo. His-
topathological examination revealed immune pathology af-
fecting the colon, lung, and liver. 5 of 11 4-mo-old CD4Cre 
dicer∆/∆ mice examined were aff ected by colitis, characterized 
by a diff use infi ltrate of infl ammatory cells in the lamina pro-
pria and focal formation of crypt abscesses (Fig. 4 c). There 
also was focal portal and lobular infl ammation in the liver in 
three mice (not depicted). The colon appeared healthy in 3-
mo-old CD4Cre dicer∆/∆ mice examined (n = 5) and in all 
dicerlox/lox controls (n = 10).
Dicer is required in a cell-autonomous fashion 
for the development of natural T reg cells in the thymus
The data presented above suggest that Dicer plays a role in 
T reg cell biology, but they do not distinguish between an 
involvement in T reg cell diff erentiation on the one hand 
and T reg cell maintenance or homeostasis on the other. It 
could be that Dicer-defi cient T reg cells diff erentiate in nor-
mal numbers but are prone to apoptosis (17), for example in 
response to the recognition of self-antigen (31, 32). Alterna-
tively, homeostatic control (33) could partially compensate 
for a more serious defect in T reg cell diff erentiation than 
is apparent by their frequency at steady-state. We therefore 
examined the fi rst wave of natural T reg cell development 
in the thymus. To exclude exchange between the thymic 
and the peripheral T cell pool, we used thymic organ culture 
initiated at embryonic day 15 (E15), when all thymocytes are 
still CD4−CD8− DN. Fetal thymi from lckCre dicer∆/∆ and 
dicerlox/lox controls were cultured for 10 d, and the frequency 
of T reg cells was evaluated (Fig. 5 a). In dicerlox/lox control 
cultures, 2.4 ± 0.3% of CD4 SP cells were CD25+ CD69− 
(n = 6), whereas in lckCre dicer∆/∆ culturesthe frequency of 
CD4 SP CD25+ CD69− cells was reduced fourfold to 0.6 ± 
0.2% (n = 11). The absolute numbers of CD4 SP CD25+ 
CD69− cells generated were 1,041 ± 296 per dicerlox/lox fetal 
thymic lobe (n = 6) versus 48 ± 22 per lckCre dicer∆/∆ lobe 
(n = 11), a diff erence of 22-fold. Analysis of Foxp3 and GITR 
expression confi rmed the ineffi  cient generation of natural T 
reg cells in lckCre dicer∆/∆ thymi (Fig. 5 a). We conclude that 
the thymic diff erentiation of natural T reg cells is compro-
mised in the absence of Dicer and mature miRNAs.
Because T reg cell diff erentiation can be driven by ex-
trinsic signals such as TGF-β (27), we asked whether T reg 
cell diff erentiation of Dicer-defi cient T cell precursors could 
be rescued by a wild-type environment. To this end, we 
constructed mixed thymus chimeras (34) consisting of a 
wild-type component marked by the Thy1.1 alloantigen and 
a Thy1.2 component of either dicerlox/lox controls or lckCre 
Figure 5. Dicer is required cell autonomously for the differentia-
tion of natural T reg cells in the thymus. (a) E15 thymi were explanted 
into organ culture and 10 d later analyzed for CD4, CD8, and T reg cell 
markers. The expression profi le of CD25 and CD69 or Foxp3 and GITR is 
shown for CD4 SP thymocytes. Note that lckCre dicer∆/∆ thymi fail to 
generate a substantial population of natural T reg cells. (b) Mixed thymus 
chimeras were constructed (reference 34) consisting of a wild-type com-
ponent marked by the Thy1.1 alloantigen and a Thy1.2 component con-
sisting of either dicerlox/lox controls or lckCre dicer∆/∆. e15-17 thymi were 
dissociated by proteolysis, mixed as indicated, reaggregated, and cultured. 
After 7–10 d, thymocytes were stained for Thy1.1, CD4, CD8, CD25, and 
GITR and analyzed by fi ve-color fl ow cytometry. The expression of CD25 
and GITR (used to defi ne T reg cells) was determined separately for 
Thy1.1+ and Thy1.1− CD4 SP cells. Note that Thy1.2 dicerlox/lox controls but 
not Thy1.2 lckCre dicer∆/∆ thymocytes generate T reg cells in mixed chi-
meras with wild-type Thy1.1 cells.
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dicer∆/∆ (see Materials and methods). Embryonic day 15–17 
thymi were dissociated by proteolysis, mixed as indicated, 
reaggregated, and cultured for 7–10 d. CD4 SP thymocytes 
that developed in these chimeras were analyzed for the pres-
ence of natural T reg cells, identifi ed by CD25 and GITR. 
Mixed chimeras containing wild-type Thy1.1 and dicerlox/lox 
Thy1.2 thymi generated distinct populations of CD25+ 
GITR+ CD4 SP thymocytes within both the Thy1.1+ 
(wild-type) and the Thy1.1− (dicerlox/lox) subset (4.2 and 
4.3%, respectively; Fig. 5 b). In contrast, mixed chimeras 
containing wild-type Thy1.1 and lckCre dicer∆/∆ Thy1.2 
thymi generated a distinct CD25+ GITR+ population only 
in the Thy1.1+ (wild-type) but not the Thy1.1− (lckCre 
dicer∆/∆) CD4 SP subset (2.7 and 0.2%, respectively; Fig. 
5 b). Hence, the impaired thymic development of Dicer-
 defi cient natural T reg cells is not rescued by the provision 
of an environment in which wild-type natural T reg cells 
develop normally.
Lack of Dicer affects the induction of Foxp3 
in peripheral CD4+CD25− T cells without diverting 
them to the IL-17 lineage
T cell activation in the presence of TGF-β induces Foxp3 
expression and T reg cell function (27), providing a model 
system for postthymic T reg cell diff erentiation. We acti-
vated CD4Cre dicer∆/∆ or control dicerlox/lox CD4+CD25− 
LN T cells with 200 ng/ml of plate-bound anti-TCR (H57) 
and anti-CD28. 2 d after exposure to 1 ng/ml TGF-β1 
(Sigma-Aldrich), 48.5 ± 15.7% of dicerlox/lox but only 13.5 ± 
4.7% of CD4Cre dicer∆/∆ cells expressed Foxp3 (n = 6; Fig. 
6 a). This demonstrates a role for Dicer in the induction of 
Foxp3 expression by environmental signals. Infl ammatory 
signals such as IL-6 have been shown to abrogate Foxp3 in-
duction by TGF-β (35) and to induce IL-17 expression 
instead (36, 37). To address the possibility that T cell 
diff erentiation was diverted toward the IL-17 lineage in the 
absence of Dicer, we restimulated the cells 5 d after activa-
tion. Intracellular staining showed no IL-17 production by 
CD4Cre dicer∆/∆ or dicerlox/lox control cells after exposure to 
TGF-β, whereas IL-17 was readily induced by the combina-
tion of TGF-β and IL-6 (Fig. 6 b).
DISCUSSION
miRNAs control the expression of a large proportion of pro-
tein-coding genes at the posttranscriptional level (6–8), and 
Dicer is essential for embryonic development (9). It was 
therefore surprising when recent studies showed that many 
aspects of T cell diff erentiation are relatively normal in the 
absence of Dicer (17, 19). Here we show that the deletion of 
Dicer results in a specifi c defect at a relatively late stage of T 
cell development. We fi nd that Dicer is required, in a cell-au-
tonomous fashion, for the development of natural T reg cells 
in the thymus, for normal T reg cell numbers in peripheral 
lymphoid organs, and for the effi  cient induction of Foxp3 in 
naive CD4 T cells by TGF-β. Around 4 mo of age, a propor-
tion (around 45%) of CD4Cre dicer∆/∆ mice develop immune 
pathology, in particular infl ammatory bowel disease. The late 
onset and incomplete penetrance of disease compared with 
mice that are genetically defi cient in Foxp3 (22, 24) may be 
due to the presence of residual Foxp3-expressing cells in 
 CD4Cre dicer∆/∆ mice. CD4Cre dicer∆/∆ T cells are predis-
posed to Th1 responses (19), which may contribute to the 
observed immune pathology.
Consistent with the importance of Dicer for T reg cell 
biology, we show that T reg cells express a characteristic set 
of miRNAs distinct from that of naive CD4 T cells, includ-
ing 7 of a set of 21 miRNAs commonly overexpressed 
in solid tumors (miR-223, miR-214, miR-146, miR-21, 
miR-24, miR-155, and miR-191; reference 38), which can 
aff ect the growth and/or the survival of tumor cells (39, 40). 
In contrast, Let-7, which negatively regulates Ras, is down-
regulated in some human tumors (41) and in T reg cells (this 
study). miRNA 21 is encoded in the 3′ UTR of the Tmem49 
gene (EMBL: AJ459711; MMU459711). Despite sixfold 
overexpression of miR-21 in T reg cells, real-time PCR 
primers in the coding region and the 3′ UTR showed no 
diff erence in mature Tmem49 mRNA levels between T reg 
cells and conventional T cells (not depicted). Intronic prim-
ers demonstrated slightly (1.6-fold) higher levels of Tmem49 
primary transcript in T reg cells, consistent with the fact that 
only nuclear transcripts are potential targets for processing by 
the nuclear RNase III Drosha (2). Similarly, mir-155 resides 
in the noncoding BIC transcript (EMBL: AY096003). BIC 
and miR-155 accumulate in B cell lymphomas, but the abun-
dance of BIC transcript does not predict the amount of 
 mature miR-155 (42). Hence, the levels of conventional 
transcripts do not predict the expression of miRNAs encoded 
Figure 6. Dicer facilitates the induction of Foxp3 in CD4+CD25− 
cells. (a) Sorted CD4Cre dicer∆/∆ or control dicerlox/lox CD4+CD25− LN T 
cells were activated with 200 ng/ml of plate-bound anti-TCR (H57) and 
anti-CD28 with or without 1 ng/ml of recombinant TGF-β1 (Sigma-
 Aldrich). Expression of Foxp3 was assayed 2 d later by intracellular staining 
(mean ± SD, n = 6). (b) CD4+CD25− LN T cells were activated as in (a) in 
the presence of 50 ng/ml IL-6 (R&D Systems) and/or 1 ng/ml TGF-β1. 
Foxp3 expression was assayed as in (a). 5 d after activation the cells were 
restimulated with PMA and Ca2+ ionophore in the presence of brefeldin A 
and assayed for IL-17 expression by intracellular staining.
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at the same location, ruling out the use of cDNA expression 
data as indicators of miRNA levels. Expression of miR-146 
is low in naive T cells and selectively up-regulated in Th1 
cells (15) and T reg cells (this study), but not in Th2 cells 
(15), whereas miR-150 is expressed in naive T cells but 
down-regulated after activation in Th1 and Th2 cells (15, 19) 
as well as in T reg cells (this study). miR-142 and members 
of the Let7 family are also down-regulated in Th1 and Th2 
cells (15) as well as in T reg cells.
The emerging picture is that T reg cells express an 
miRNA profi le similar to that of acutely activated CD4 T 
cells. This brings into focus the knowledge that T reg cells 
constitutively express CD25, CTLA4, and GTIR, markers 
that are also induced by the activation of conventional CD4 
T cells (20, 21), even though most T reg cells in peripheral 
LNs are CD69− CD62Lhigh and not actively dividing (31). 
From this perspective, one could argue that T reg cells may 
be locked in a partially activated state. Understanding the 
molecular mechanisms that maintain this state in natural T 
reg cells will be key to their biology. Interestingly, our data 
show that the ectopic expression of the T reg cell signature 
transcription factor Foxp3 can confer a partial T reg cell 
miRNA profi le. Hence, aspects of the T reg cell–specifi c 
miRNA profi le may be under the direct or indirect control 
of Foxp3. It remains to be investigated whether Foxp3 is un-
der miRNA control. In addition to the extensive overlap be-
tween the miRNA profi le of T reg cells and activated T cells, 
our analysis has identifi ed miRNAs that are overexpressed by 
T reg cells but not by activated T cells, for example miR-223 
and miR-146. Detailed studies on the mRNA targets of these 
and other T reg cell–expressed miRNAs may provide further 
clues to how T reg cells develop and are maintained over 
time. The systemic manipulation of miRNA function (43) 
may open new avenues for the control of T reg cell develop-
ment and function in vivo.
MATERIALS AND METHODS
Mice, fl ow cytometry, and cell sorting. Animal work was performed 
according to the Animals (Scientifi c Procedures) Act, UK. dicerlox/lox mice (17) 
on a mixed C57BL/129 background were crossed with LckCre or CD4Cre 
transgenic mice (16) to generate lckCre dicer∆/∆ or CD4Cre dicer∆/∆ mice 
and held in a conventional facility where they encountered Pasteurella 
 pneumotropica and Tritrichomonas muris but no other identifi ed pathogens, such 
as MHV or Sendai virus. Cells were stained, analyzed, and sorted by fl ow 
cytometry as described previously (17). The following antibodies were used: 
CD25-PE, CD25-APC, CD69-FITC, and Thy1.1-biotin (BD Biosciences); 
CD4-TC and CD8-PE (Caltag); GITR-FITC (R&D Systems); Streptavi-
din-Alexa-405 (Invitrogen); and Foxp3-PE and Foxp3-APC (eBioscience). 
Cells were analyzed or sorted on Becton Dickinson Calibur, DIVA, or Aria 
fl ow cytometers.
Cell and tissue culture. LN T cells were activated at 1–3 × 106/ml with 
200 ng/ml of plate-bound anti–TCR-β (H57; BD Biosciences) and 2 μg/
ml anti-CD28 (BD Biosciences). For induction of Foxp3 expression, we 
added 1 ng/ml TGF-β (Sigma-Aldrich). Retroviral gene transfer was per-
formed by spin infection of overnight-activated T cells (90 min, 2,000 rpm, 
37°C, without polybrene) using mouse stem cell virus vectors as described 
previously (44). Fetal thymic organ culture, reaggregate culture, and mixed 
thymic chimeras were established and cultured as described previously (34).
miRNA microarray analysis. Probes for 173 miRNAs referenced in 
miRBase (29) were synthesized in sense orientation (Sigma-Aldrich) and 
spotted on glass slides in 16 replicates. Low molecular weight RNA was 
isolated using the MirVana kit (Ambion) and miRNAs were reverse 
 transcribed using the 3DNA Array Detection 900 miRNA RT kit (Geni-
sphere). 100 ng of small RNAs were tailed with poly(A) polymerase and 
reverse transcribed using a poly(dT) primer and a unique capture sequence. 
The tagged cDNAs were concentrated with Microcon YM-10 columns 
(Millipore), resuspended in 60 μl hybridization buff er (18.5% formamide, 
5xSSC, 5x Denhardt’s solution, 0.5% SDS, 5mM KH2PO4), denatured 
at 95°C for 5 min, and hybridized to the array at 42°C overnight. Arrays 
were developed with Cy3- and Cy5-coupled DNA oligonucleotides 
with reverse complementary to the capture sequences and scanned with a 
GenePix 4000B scanner using Genepix Pro 5.0 (Axon). Data analysis was 
performed in Acuity (Molecular Dynamics). Data was fi ltered by removing 
spots with <55% of pixels one standard deviation above background after 
subtracting median background values. Cy3/Cy5 ratios were log(2) trans-
formed and normalized by Lowess, and in some cases by median centering, 
and the average ratio of replicates was calculated for each miRNA that 
passed the fi lter criteria. To eliminate dye bias, each experiment was hy-
bridized to two separate arrays, swapping the dye of each sample. Data 
were subjected to SAM as described previously (30), accepting a false posi-
tive rate of 0.068.
RT-PCR and Northern blots. Total RNA was isolated using RNAbee 
(Tel-Test) and reverse transcribed. Real-time PCR analysis was performed 
on an Opticon DNA engine (95°C for 15 min followed by 40 cycles at 94°C 
for 15 s, 60°C for 30 s, and 72°C for 30 s with a plate read at 72°C; MJ 
Research Inc.) and normalized to the geometric mean of Ywhaz (tyrosine 
3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta 
polypeptide) and Ube2L3 (ubiquitin conjugating enzyme E2L3) as described 
previously (17). Primer sequences (5′ to 3′) are as follows: Ywhaz forward: 
C G T T G T A G G A G C C C G T A G G T C A T , Ywhaz reverse: T C T G G T T G C-
G A A G C A T T G G G ; Ube2L3 forward: A G G A G G C T G A T G A A G G A G C T-
T G A , Ube2L3 reverse: T G G T T T G A A T G G A T A C T C T G C T G G A ; Foxp3 
forward: A C T C G C A T G T T C G C C T A C T T C A G , Foxp3 reverse: G G C G G A-
T G G C A T T C T T C C A G G T ; Tmem49 forward: G C C T G T G C T T C T A T T C-
C A A A C C , Tmem49 reverse: G A A A G T C A C C A T C T G C T C C A ; Tmem49 
3′UTR forward: G T T G A A T C T C A T G G C A A C A G C A G T C , Tmem49 
3′UTR reverse: A A G G G C T C C A A G T C T C A C A A G A C A ; and Tmem49 in-
tron 11 forward: A G A A C C A G C A G A T G T G T A G G C A G C , Tmem49 intron 
11 reverse: G G G A A G A G G A C C T A A A C T C T G A G A G C .
For quantitative real-time RT-PCR of miRNAs, gene-specifi c reverse 
transcription was performed for each miRNA using 10 ng of low molecular 
weight RNA, 1 mM dNTPs, 50 U MutliScribe reverse transcriptase, 3.8 U 
RNase inhibitor, and 50 nM of gene-specifi c RT primer samples using the 
TaqMan MicroRNA Reverse Transcription kit (Applied Biosystems). 15-μl 
reactions were incubated for 30 min at 16°C, 30 min at 42°C, and 5 min at 
85°C to inactivate the reverse transcriptase. Real time RT-PCR reactions 
(1.35 μl of RT product, 10 μl TaqMan 2x Universal PCR master Mix, 
No AmpErase UNG [Applied Biosystems], and 10 μl TaqMan MicroRNA 
Assay Mix containing PCR primers and TaqMan probes) were run in tripli-
cates at 95°C for 10 min followed by 40 cycles at 95°C for 15 s and 60°C for 
1 min. Expression values were normalized to miR-17-5p. Gene-specifi c RT 
primers and TaqMan MicroRNA Assay Mix were from the TaqMan Mir-
coRNA Assays Human Panel Early Access kit (Applied Biosystems). North-
ern blots were performed as described previously (17).
Histology. Tissues were fi xed in 10% neutral-buff ered formalin, embedded 
in paraffi  n, sectioned, and stained with hematoxylin and eosin and with 
 periodic acid-Schiff  for microscopic examination.
Online supplemental material. Fig. S1 shows the kinetics of miRNA 
 expression after the activation of naive CD4 T cells. It is available at http://
www.jem.org/cgi/content/full/jem.20061692/DC1.
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